SEMA4D Blockade Safety and Brain Metabolic Activity in Alzheimer's Disease (AD)
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Eric Siemers, MD
Vaccinex Inc.
Study Director
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
14 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Pacific Research Network, Inc
San Diego, California, United States
- Georgetown University
Washington D.C., District of Columbia, United States
- Brain Matters Research
Delray Beach, Florida, United States
- Neuropsychiatric Research Center of Southwest Florida
Fort Myers, Florida, United States
- Jem Research Institute
Lake Worth, Florida, United States
- Premiere Research Institute of Palm Beach, Neurology
Palm Beach, Florida, United States
- Brain Matters Research
Stuart, Florida, United States
- Indiana University School of Medicine
Indianapolis, Indiana, United States
- University of Kansas Medical Center
Fairway, Kansas, United States
- Neurological Associates of Albany
Albany, New York, United States
- Dent Neurological Associates
Amherst, New York, United States
- Columbia University Irving Medical Center
New York, New York, United States
- University of Rochester Medical Center
Rochester, New York, United States
- Re-Cognition Health
Fairfax, Virginia, United States
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 22 Jul 2021
- Primary completion
- 5 Jun 2024
- Completion
- 5 Jun 2024
- Last update posted
- 22 Aug 2024
- Registered enrollment
- 50
- Registry id
- NCT04381468
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.